ArticleBritish journal of cancer2008
Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse.
Article in British journal of cancer, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 94 citations in OpenAlex.
- Can magnetic resonance imaging replace conventional computerized tomography for follow-up of patients with testicular cancer? A systematic review.World journal of urology · 2022Pooled it
- [Follow-up of testicular germ cell cancer patients: interdisciplinary evidence-based recommendations].Der Urologe. Ausg. A · 2011Guideline
- Germ cell tumours of the testis: 10-year survival data from a tertiary care centre in India.Ecancermedicalscience · 2025Article
- Article
- Unveiling the genomic landscape of possible metastatic malignant transformation of teratoma secondary to cisplatin-chemotherapy: a Tempus gene analysis-based case report literature review.Frontiers in oncology · 2023Article
- The Role of CT in the Staging and Follow-Up of Testicular Tumors: Baseline, Recurrence and Pitfalls.Cancers · 2022Review
- Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors.European urology open science · 2022Article
- [Follow-up of testicular germ cell tumors-historical aspects and current recommendations].Der Urologe. Ausg. A · 2022Review
- Actual frequency of imaging during follow-up of testicular cancer in Israel-a comparison with the guidelines.European radiology · 2019Article
- Whole Body MRI and oncology: recent major advances.The British journal of radiology · 2018Review
- "Off-Label" Usage of Testicular Self-Examination (TSE): Benefits Beyond Cancer Detection.American journal of men's health · 2018Article
- Recommendations for followup of stage I and II seminoma: The Princess Margaret Cancer Centre approach.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2018Review
- Erratum to: Dendritic cells as therapeutic targets in neuroinflammation.Cellular and molecular life sciences : CMLS · 2016Article
- Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal Carcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2016Article
- Prostatic relapse of an undifferentiated teratoma 24 years after orchidectomy.BMC research notes · 2015Article
- External validation of the Heidenreich criteria for patient selection for unilateral or bilateral retroperitoneal lymph node dissection for post-chemotherapy residual masses of testicular cancer.World journal of urology · 2014Article
- Comment on 'Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'.British journal of cancer · 2013Article
- Clinical outcomes in patients with stage I non-seminomatous germ cell cancer.Asian journal of andrology · 2013Article
- Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.Diagnostic pathology · 2013Article
- Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.Annals of oncology : official journal of the European Society for Medical Oncology · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 5 institutions in 1 country.
Funding
Abstract
Testicular germ cell tumours (TGCTs) are the most common cause of cancer in men between the ages of 15 and 40 years, and, overall, the majority of patients should expect to be cured. The European Germ Cell Cancer Consensus Group has provided clear guidelines for the primary treatment of both seminoma and nonseminomatous germ cell tumours. There is, however, no international consensus on how best to follow patients after their initial management. This must promptly and reliably identify relapses without causing further harm. The standardising of follow-up would result in optimising risk-benefit ratios for individual patients, while ensuring economic use of resources. We have identified the seven common scenarios in managing seminomas and nonseminomas of the various stages and discuss the pertinent issues around relapse and follow-up. We review the available literature and present our comprehensive TGCT follow-up guidelines. Our protocols provide a pragmatic, easily accessible user-friendly basis for other centres to use or to adapt to suit their needs. Furthermore, this should enable future trials to address specific issues around follow-up giving meaningful and useful results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.